FDA Approves ‘First-Of-Its-Kind’ Corneal Implant
Published at
byakkaya/iStock/Thinkstock(NEW YORK) — The U.S. Food and Drug Administration this week approved a “first-of-its-kind” corneal implant meant to help improve near vision in some patients.
The KAMRA inlay is implanted in the cornea of one eye to help patients with presbyopia, the FDA says. The device is ring-shaped and works by blocking unfocused light rays from entering the eye, removing blurriness. “Presbyopia is a natural part of aging and can make reading and performing close-up work difficult,” William Maisel, deputy center director for science in the FDA’s Center for Devices and Radiological Health said in a press release. “The KAMRA inlay provides a new option for correcting near vision in certain patients.”
An FDA press release says the agency looked at three clinical studies, which showed that 83.5 percent of evaluable participants improved their near vision to 20/40 or better within a year.
Follow @ABCNewsRadio
Copyright © 2015, ABC Radio. All rights reserved.